Hypoplastic coronary artery disease: A rare cause of sudden cardiac death and its treatment with an implantable defibrillator  by McFarland, Craig et al.
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Summary  A  21-year-old  African  American  male  presented  to  the  emergency  department
after an  episode  of  unexplained  syncope.  He  had  no  signiﬁcant  past  medical  history.  The  initial
physical  examination  was  within  normal  limits,  and  his  12-lead  electrocardiogram  showed  no
signs of  ischemia  or  evidence  of  chamber  enlargement.  The  patient  received  a  transthoracic
echocardiogram  which  demonstrated  mild  global  left  ventricular  dysfunction  with  an  estimated
ejection fraction  of  45%.  Coronary  angiography  was  next  performed  and  found  no  evidence  of
atherosclerotic  coronary  artery  disease  but  did  reveal  hypoplasia  of  the  left  circumﬂex  and
right coronary  arteries,  with  intraluminal  diameters  of  approximately  1  mm.  The  left  anterior
descending  coronary  artery  was  small  distally.  Cardiac  magnetic  resonance  imaging  with  gadolin-
ium enhancement  found  no  evidence  of  myocardial  scar.  The  patient  was  ultimately  diagnosed
with aborted  sudden  cardiac  death  due  to  hypoplastic  coronary  artery  disease  (HCAD).  The
patient received  an  implantable  cardioverter-deﬁbrillator  (ICD)  prior  to  hospital  discharge  for
secondary prevention  of  sudden  cardiac  death.  One  year  after  this  presentation,  the  patient
has been  asymptomatic,  with  no  ICD  discharges.
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ntroductionypoplastic  coronary  artery  disease  (HCAD)  is  a  rare  con-
ition  in  which  the  coronary  arteries  are  abnormally  small.
udden  cardiac  death  (SCD)  has  been  reported  as  an  initial
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resentation  of  this  condition,  and  opportunities  for  treat-
ent  are  rare.  We  present  a  case  in  which  a  previously
symptomatic  young  male  was  diagnosed  with  HCAD  follow-
ng  a  syncopal  episode  and  was  treated  with  a  prophylactic
mplantable  cardioverter-deﬁbrillator  (ICD).ase  report
 21-year-old  male  presented  to  the  emergency  depart-
ent  after  losing  consciousness  while  walking  in  the  park.
 Published by Elsevier Ltd. All rights reserved.
Treatment  of  hypoplastic  coronary  artery  disease  with  an  implantable  deﬁbrillator  e149
Figure  1  M-mode  echocardiography  using  fractional  shortening  (FS)  to  estimate  left  ventricular  function.  This  image  reveals  FS
of 26%,  consistent  with  mild  left  ventricular  dysfunction.  Lines  with  arrows  indicate  left  ventricular  internal  dimension  in  systole
(LVIDs) and  left  ventricular  internal  dimension  in  diastole  (LVIDd).
Figure  2  Coronary  artery  angiograms.  (A)  Left  anterior  oblique  view  of  the  patient’s  hypoplastic  right  coronary  artery  (RCA,  with
arrows). (B)  Right  anterior  oblique  view  of  the  patient’s  normal  left  main  (LM),  hypoplastic  left  circumﬂex  (LCx),  and  distally  small
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He  experienced  dyspnea  and  palpitations  just  before  the
episode,  but  no  chest  pain.  Bystanders  witnessed  no  tonic
clonic  movements  suggestive  of  seizure  activity.  The  patient
had  never  previously  experienced  a  syncopal  episode.  He
had  no  signiﬁcant  past  medical  history  and  took  no  medi-
cations.  He  reported  some  tobacco  use,  but  no  history  of
alcohol  or  illicit  drug  abuse.  He  did  report  a  family  history
of  an  ‘‘enlarged  heart’’  in  a  brother,  as  well  as  a  history  of
sudden  death  in  several  great  aunts.The  patient’s  physical  exam  was  unremarkable.  He  was  a
thin  male  in  no  distress  and  was  fully  alert  and  oriented.
Cardiac  auscultation  was  unremarkable.  Laboratory  stud-
ies  revealed  electrolytes  within  the  normal  range,  a  blood
w
o
chy  catheter,  indicated  by  black  diamonds,  is  2  mm  in  caliber.
lucose  of  77  mg/dL,  and  a  normal  hemoglobin  level  and
hite  cell  count.  Toxicology  screen  for  illicit  drugs  was  nega-
ive.  His  12-lead  electrocardiogram  (ECG)  showed  mild  sinus
radycardia  at  52  beats  per  minute  but  no  ST  segment  abnor-
alities  or  chamber  enlargement.  The  patient  received
 transthoracic  echocardiogram  which  demonstrated  mild
lobal  left  ventricular  dysfunction  with  an  estimated  ejec-
ion  fraction  of  45%  as  well  as  a  moderately  dilated  right
entricle  with  mildly  reduced  performance  (Fig.  1).  There
as  no  signiﬁcant  chamber  hypertrophy,  intracardiac  shunt,
r  evidence  of  valvular  disease.
Due  to  these  abnormal  echocardiogram  ﬁndings,  cardiac
atheterization  was  performed,  revealing  narrowed  lumens
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f  all  three  of  the  patient’s  major  epicardial  coronary  artery
ranches  (Fig.  2).  The  right  coronary  artery  had  a  normal
stium  but  a  maximal  diameter  of  approximately  1  mm  along
ts  entire  length.  The  left  coronary  artery  ostium  was  also
ithout  abnormality,  and  the  left  main  artery  had  a  normal
aliber  of  approximately  4  mm.  The  left  circumﬂex  coronary
rtery,  however,  had  a  maximal  diameter  of  approximately
 mm.  The  left  anterior  descending  artery  (LAD)  was  of
ormal  caliber  proximally  but  was  small  distally,  with  a
iameter  of  under  2  mm  in  its  distal  segment.  A  myocardial
ridge  was  identiﬁed  at  the  mid-portion  of  the  LAD.  Intralu-
inal  infusion  of  nitroglycerin  did  not  change  the  caliber  of
he  arteries.  Computed  tomography  angiography  conﬁrmed
he  above  ﬁndings;  subsequent  cardiac  magnetic  resonance
maging  with  gadolinium  enhancement  found  no  evidence  of
car.  A  24-h  Holter  monitor  recorded  no  abnormalities.
The  abnormally  small  coronary  arteries  were  consistent
ith  HCAD.  In  the  absence  of  any  other  identiﬁed  cause  of
he  patient’s  syncope,  he  was  diagnosed  with  aborted  SCD
ue  to  insufﬁcient  myocardial  perfusion,  and  an  ICD  was
mplanted.  Prior  to  implantation,  the  patient  underwent  an
lectrophysiology  study  with  various  pacing  maneuvers;  no
nducible  arrhythmias  were  noted.  However,  based  on  the
linical  context,  it  was  determined  that  the  patient  would
till  beneﬁt  from  ICD  placement  for  the  secondary  preven-
ion  of  SCD.  The  patient  was  discharged  on  metoprolol  and
isinopril  for  his  systolic  dysfunction  and  one  year  later,  the
atient  is  doing  well,  with  no  episodes  of  syncope,  symp-
oms  of  cardiac  ischemia,  heart  failure  symptoms,  or  ICD
ischarges.
iscussion
CAD  is  a  rare  congenital  malformation  in  which  at  least  one
f  the  major  epicardial  artery  branches  is  underdeveloped.
oronary  artery  anomalies  have  an  incidence  of  approxi-
ately  1%  in  the  general  population,  and  one  postmortem
urvey  identiﬁed  HCAD  in  2.2%  of  patients  with  coronary
rtery  anomalies  [1,2]. In  a  postmortem  analysis  of  ath-
etes  who  experienced  sudden  death,  hypoplastic  coronary
rteries  were  identiﬁed  in  less  than  5%  of  total  patients  and
omprised  less  than  33%  of  observed  congenital  coronary
rtery  anomalies  [3].  The  hypoplasia  of  HCAD  can  manifest
s  a  narrowed  luminal  diameter  or  a  shortened  course,  and
s  typically  present  in  one  or  two  of  the  three  major  epi-
ardial  branches.  A  luminal  diameter  of  less  than  1.5  mm
ith  no  nearby  compensatory  branches  has  been  proposed
s  a  criterion  for  diagnosis  [4].  The  case  we  present  here
ppears  to  be  particularly  severe:  the  right  and  left  circum-
ex  coronary  arteries  were  markedly  hypoplastic,  while  the
eft  anterior  descending  artery  was  small  distally.
SCD  is  a  common  presentation  of  the  condition,  likely
rom  arrhythmia  triggered  by  myocardial  ischemia  [4].  In
ome  of  these  cases,  symptoms  such  as  syncope,  palpi-
ations,  dyspnea,  and  chest  pain  are  present  beforehand,
hile  in  many  cases  SCD  is  the  ﬁrst  manifestation.  HCAD
n  cases  of  SCD  is  typically  diagnosed  during  postmortem
utopsy  [5].  The  mechanisms  of  myocardial  ischemia  in  coro-
ary  artery  anomalies  are  not  well  elucidated,  and  ischemia
n  such  patients  is  difﬁcult  to  predict  and  to  reproduce  dur-
ng  stress  testing  [1].  HCAD  may  be  no  different:  thrombosis,C.  McFarland  et  al.
oronary  artery  spasm,  a  milking  effect  by  a  myocardial
ridge,  and  exertion  may  exacerbate  limitations  to  ﬂow
lready  imposed  by  narrowed  coronary  artery  lumens  [1,4].
Uncommonly,  HCAD  is  diagnosed  in  living  patients.  In  one
f  these  cases,  HCAD  was  diagnosed  in  an  11-year-old  boy
uring  a  coronary  angiogram  following  symptoms  of  myocar-
ial  infarction;  he  experienced  SCD  4  years  later  during
ntense  physical  exertion  [6,7]. In  another  case,  a  20-year-
ld  man  with  myocardial  infarction  was  found  to  have  HCAD
8].
Few  options  are  available  for  the  treatment  of  HCAD
n  such  cases.  Bypass  surgery  is  not  feasible  due  to  the
iffuse  distribution  of  disease,  although  transmyocardial
evascularization  may  be  an  alternative  method  of  improv-
ng  myocardial  perfusion  in  HCAD  patients.  Heart  transplant
an  be  undertaken  when  HCAD  is  accompanied  by  advanced
eart  failure.  Due  to  the  heightened  risk  of  arrhythmia  and
CD,  ICD  implantation  has  been  suggested  for  HCAD;  the
eneﬁts  of  ICDs  in  older  adults  at  risk  for  ventricular  arrhyth-
ia  may  extend  to  younger  patients  with  congenital  heart
isease  [6,9]. In  no  prior  reported  cases  in  the  literature  has
he  implantation  of  an  ICD  for  SCD  prevention  been  used  for
CAD.  In  the  case  of  the  11-year-old  boy  mentioned  above,
ediatric  ICD  implantation  was  not  routinely  performed  at
he  hospital  of  treatment.  An  ICD  was  not  used  in  the  case  of
he  20-year-old  man  mentioned  above  either,  as  the  authors
oted  that  he  did  not  have  persistent  myocardial  ischemia;
eriodic  electrophysiologic  monitoring  was  instead  chosen.
In  the  case  presented  here,  it  was  felt  that  the  beneﬁt
rom  reduction  of  SCD  risk  outweighed  the  adverse  effects
f  ICD  implantation,  even  given  a  lack  of  deﬁnitive  proof
hat  aborted  SCD  had  occurred.  Further  testing,  such  as
 vasospasm  provocation  and  stress  perfusion  testing,  may
ave  provided  insight  into  the  mechanisms  of  ischemia  in  this
atient.  Given  the  poorly  deﬁned  triggers  of  ischemia  and
rrhythmia  in  HCAD,  however,  ICD  implantation  was  felt  to
e  necessary  regardless  of  the  results  of  such  tests.  Indeed,
ecent  guidelines  state  that  ICD  implantation  is  reason-
ble  in  congenital  heart  disease,  including  coronary  artery
alformations,  in  patients  with  unexplained  episodes  of  syn-
ope  who  also  have  impaired  ventricular  function  and  are  on
ong-term  treatment  for  heart  failure  [10]. Until  our  under-
tanding  of  coronary  artery  anomalies  and  the  means  by
hich  they  cause  SCD  are  better  elucidated,  ICD  placement
ay  be  a  prudent  choice  for  some  patients  with  HCAD.
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